查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
子宫内膜异位症治疗市场规模、份额和趋势分析报告：按治疗类型、药物类别 (NSAID)、给药途径、分销渠道、地区和细分市场预测，2023-2030 年
市场调查报告书
商品编码
1171058

子宫内膜异位症治疗市场规模、份额和趋势分析报告：按治疗类型、药物类别 (NSAID)、给药途径、分销渠道、地区和细分市场预测，2023-2030 年

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class (NSAIDs), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

子宫内膜异位症治疗市场的增长和趋势

根据 Grandview Research 的一份新报告，到 2030 年，全球子宫内膜异位症治疗市场预计将达到 32 亿美元。从 2023 年到 2030 年，该市场预计将以 13.5% 的复合年增长率增长。市场增长归因于强大的后期产品管道的存在、全球病例的激增，以及政府和大公司在国家和国际层面采取的几项提高疾病意识的举措。

太空中新治疗方案的不断研究和开发预计将为未来几年的市场增长提供有利可图的机会。Myovant/Pfizer的 Relugolix 组合片剂、ObsEva 的 Yselty (linzagolix) 和 Ferring Pharmaceuticals/Novartis 的 Quinagolide 预计将作为该领域的主要药物推动市场增长。

对子宫内膜异位症治疗的需求不断增长，原因是疾病负担增加和诊断延迟导致病情恶化。2021 年 3 月，世界卫生组织宣布全球约有 10% 的女性生殖人群受到该病的影响。根据论文“子宫内膜异位症诊断延迟对医疗保健资源利用和成本的影响”，与症状出现后较早诊断的患者相比，首次症状出现后延迟诊断超过 3 年会增加症状负担，导致 50% 的增加医疗费用。

世卫组织、各国政府和私人组织正在战略性地努力提高人们对子宫内膜异位症及其治疗的认识，这有助于市场的增长。例如，2022 年 3 月，美国子宫内膜异位症基金会举办了四个週末的虚拟患者和医生主演计划，以帮助连接子宫内膜异位症勇士并分享他们与疾病的经验。此外，2022年3月，英国子宫内膜异位症协会还在子宫内膜异位症行动月期间推出了八点行动计划。

此外，主要参与者正在通过併购、合作伙伴关係、金融投资和地域扩张等战略努力来推动子宫内膜异位症治疗市场。例如，2021 年 11 月，Organon and Co. 宣布将收购 Forendo Pharma，以帮助开发治疗子宫内膜异位症的新药，包括 Forendo 的 2 期临床候选药物 OR-6219。

子宫内膜异位症药物市场报告要点

从治疗类型来看，由于医生处方率高，激素治疗领域将在 2022 年占据最大份额。

由于 GnRH 激动剂和 GnRH 拮抗剂的高效和市场可用性增加，促性腺激素释放激素 (GnRH) 细分市场在 2022 年占据主导地位

到 2022 年，口服製剂将以 48.46% 的给药途径份额主导市场。口服製剂是该领域大多数产品最常见和最方便的给药途径。

到 2022 年，零售药店将通过分销渠道主导市场。此外，预计医院药房将出现适度增长。

由于疾病发病率的增加以及人们和医疗保健专业人员对疾病治疗的高度认识，2021 年的全球市场由北美主导。

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 段范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库：
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 第一次调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法：产品流方法
  • 调查假设
  • 二级信息列表
  • 缩略语表
  • 目的

第二章执行摘要

  • 市场快照
  • 段快照
  • 争用快照

3 子宫内膜异位症治疗：市场变量、趋势和范围

  • 市场系列展望
  • 绘製渗透率和增长前景
  • 监管状况
  • 市场动态
  • 市场驱动力分析
    • 疾病负担加重
    • 疾病意识的增强
    • 增加研发资金
  • 市场约束因素分析
    • 非处方药和仿製药的可用性
  • PESTEL 分析
  • 行业分析——波特五力
  • 管道分析

4 子宫内膜异位症治疗市场：细分分析，按治疗类型，2018-2030 年（百万美元）

  • 子宫内膜异位症治疗市场：治疗类型变化分析
  • 止痛药
  • 激素疗法

5 子宫内膜异位症治疗市场：细分分析，按药物类别，2018-2030 年（百万美元）

  • 子宫内膜异位症治疗：药物类别变异分析
  • 非甾体抗炎药
  • 口服避孕药
  • 促性腺激素释放激素
  • 其他

6 子宫内膜异位症治疗市场：细分分析，按给药途径，2018-2030 年（百万美元）

  • 子宫内膜异位症治疗市场：给药途径、变异分析
  • 口服
  • 可注射的
  • 其他

第 7 章子宫内膜异位症治疗市场：细分分析，按分销渠道，2018-2030 年（百万美元）

  • 子宫内膜异位症治疗市场：分销渠道、变化分析
  • 医院药房
  • 零售药店
  • 其他

8 子宫内膜异位症治疗市场：细分分析，按地区，2018-2030 年（百万美元）

  • 区域市场快照
  • 2021 年和 2030 年区域市场份额分析
  • 市场规模、预测以及收入和趋势分析，2021-2030 年
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 法国
      • 意大利
      • 丹麦
      • 瑞典
      • 挪威
      • 欧洲其他地区
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 澳大利亚
      • 韩国
      • 泰国
      • 亚太地区其他国家
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 拉丁美洲其他地区
    • 多边环境协定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 科威特
      • MEA分辨率

第九章子宫内膜异位症治疗市场：竞争分析

  • 战略举措和影响分析：主要市场参与者
    • 协同效应分析：重大交易和战略联盟
      • 新产品发布
      • 併购
      • 许可协议
  • 公司分类
    • 创新者
    • 市场领导者
    • 新兴玩家
    • 热图分析
  • 公司市场分析
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
    • 潜在最终用户列表
    • 2021 年主要参与者的市场份额分析
    • 消费者行为分析
    • 竞争仪錶盘分析
  • 民营企业
    • 主要初创企业名单
    • 区域网络图
  • 公司简介
    • Bayer AG
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Pfizer, Inc
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AbbVie, Inc
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AstraZeneca
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • ObsEva SA
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Teva Pharmaceutical Industries
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Zydus Healthcare Limited
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Eli Lilly and Company
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Astellas Pharma Inc
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-4-68040-005-5

Endometriosis Treatment Market Growth & Trends:

The global endometriosis treatment market size is expected to reach USD 3.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is exected to expand at a CAGR of 13.5% from 2023 to 2030. The market growth is attributed to the presence of a late-stage robust product pipeline, the global upsurge in cases, and several initiatives undertaken by the government and key players at national and international levels to raise disease awareness.

The growing research and development for new treatment options in space is expected to offer a lucrative opportunity for market growth in the coming years. The launch of Myovant / Pfizer's Relugolix combination tablet, ObsEva's Yselty (linzagolix), and Ferring Pharmaceuticals / Novartis' Quinagolide are among prominent drug launches in this space that are anticipated to fuel the market growth.

Rising demand for endometriosis treatment is attributed to increasing disease burden and delay in diagnosis, worsening the disease condition. In March 2021, as per WHO, approximately 10% of female reproductive population is affected by the disease worldwide. According to the article, "Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs", a delay of three or more years in diagnosis from developing first symptom leads to increase in symptom burden and increase in healthcare cost by 50% compared with patients who were diagnosed earlier after symptom onset.

WHO, national governments, and private organizations are strategically involved in spreading awareness and educating people about endometriosis and its treatment, thereby supporting market growth. For instance, in March 2022, the Endometriosis Foundation of America hosted four weekends of the virtual program featuring patients and physicians, helping to connect endometriosis warriors and share their experiences with the disease. Moreover, in March 2022, Endometriosis U.K. also launched an eight-point action plan during the 'Endometriosis Action Month'.

Furthermore, key players are undertaking strategic initiatives such as mergers and acquisitions, collaborations, financial investments, and geographical expansion fueling the endometriosis treatment market. For instance, in November 2021, Organon and Co. announced to acquire Forendo Pharma, which will support Forendo's development of novel drugs in endometriosis like OR-6219, a phase 2 clinical candidate.

Endometriosis Treatment Market Report Highlights:

  • By treatment type, the hormone therapy segment accounted for the largest share of the market in 2022 due to the high prescription rate of these drugs by physicians
  • Gonadotropin-releasing hormone (GnRH) segment dominated the drug class segment in 2022 due to the high efficacy of GnRH agonists and GnRH antagonists and the increased availability of these products in the market
  • In 2022, oral segment dominated the market with a 48.46% share by route of administration. It is the most common & convenient route of delivery for the majority of products in this space
  • In 2022, retail pharmacy segment dominatedthe market by distribution channel. Moreover, hospital pharmacy is expected to demonstrate moderate growth
  • North America dominated the global market in 2021 owing to increased disease incidence and high awareness among people and healthcare professionals about the condition therapies

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation and Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Endometriosis Treatment: Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
  • 3.5 Market Driver Analysis
    • 3.5.1 Rising disease burden
    • 3.5.2 Growing awareness for the disease
    • 3.5.3 Increasing funding for research and development
  • 3.6 Market Restraint Analysis
      • 3.6.1.1 Availability of over the counter and generic drugs
  • 3.7 PESTEL Analysis
  • 3.8 Industry Analysis-Porter's Five Forces
  • 3.9 Pipeline Analysis

Chapter 4 Endometriosis Treatment Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

  • 4.1 Endometriosis Treatment Market: Treatment Type Movement Analysis
  • 4.2 Pain Medication
    • 4.2.1 Pain Medication Market, 2018 - 2030 (USD Million)
  • 4.3 Hormonal Therapy
    • 4.3.1 Hormonal Therapy Market, 2018 - 2030 (USD Million)

Chapter 5 Endometriosis Treatment Market: Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)

  • 5.1 Endometriosis Treatment: Drug Class Movement Analysis
  • 5.2 NSAIDs
    • 5.2.1 NSAIDs Market, 2018 - 2030 (USD Million)
  • 5.3 Oral Contraceptive
    • 5.3.1 Oral Contraceptive Market, 2018 - 2030 (USD Million)
  • 5.4 Gonadotropin Releasing Hormone
    • 5.4.1 Gonadotropin Releasing Hormone, Market, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Endometriosis Treatment Market: Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)

  • 6.1 Endometriosis Treatment Market: Route of Administration, Movement Analysis
  • 6.2 Oral
    • 6.2.1 Oral Market, 2018 - 2030 (USD Million)
  • 6.3 Injectable
    • 6.3.1 Injectable Market, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Endometriosis Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 7.1 Endometriosis Treatment Market: Distribution Channel, Movement Analysis
  • 7.2 Hospital pharmacy
    • 7.2.1 Hospital pharmacy Market, 2018 - 2030 (USD Million)
  • 7.3 Retail pharmacy
    • 7.3.1 Retail pharmacy Market, 2018 - 2030 (USD Million)
  • 7.4 Others
    • 7.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Endometriosis Treatment Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Regional Market Snapshot
  • 8.2 Regional Market Share Analysis, 2021 & 2030
  • 8.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2021 to 2030
    • 8.3.1 North America
      • 8.3.1.1 North America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.2 U.S.
      • 8.3.1.2.1 U.S. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.3 Canada
      • 8.3.1.3.1 Canada Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Europe
      • 8.3.2.1 Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.2 U.K.
      • 8.3.2.2.1 U.K. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.3 Germany
      • 8.3.2.3.1 Germany Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.4 Spain
      • 8.3.2.4.1 Spain Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.5 France
      • 8.3.2.5.1 France Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.6 Italy
      • 8.3.2.6.1 Italy Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.7 Denmark
      • 8.3.2.7.1 Denmark Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.8 Sweden
      • 8.3.2.8.1 Sweden Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.9 Norway
      • 8.3.2.9.1 Norway Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.10 Rest of Europe
      • 8.3.2.10.1 Rest of Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 Asia Pacific
      • 8.3.3.1 Asia Pacific Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.2 Japan
      • 8.3.3.2.1 Japan Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.3 China
      • 8.3.3.3.1 China Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.4 India
      • 8.3.3.4.1 India Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.5 Australia
      • 8.3.3.5.1 Australia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.6 South Korea
      • 8.3.3.6.1 South Korea Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.7 Thailand
      • 8.3.3.7.1 Thailand Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.8 Rest of APAC
      • 8.3.3.8.1 Rest of APAC Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Latin America
      • 8.3.4.1 Latin America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.4.2 Brazil
      • 8.3.4.2.1 Brazil Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.4.3 Mexico
      • 8.3.4.3.1 Mexico Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.4.4 Argentina
      • 8.3.4.4.1 Argentina Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.4.4 Rest of LATAM
      • 8.3.4.5.1 Rest of LATAM Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 MEA
      • 8.3.5.1 MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.2 South Africa
      • 8.3.5.2.1 South Africa Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.3 Saudi Arabia
      • 8.3.5.3.1 Saudi Arabia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.4 UAE
      • 8.3.5.4.1 UAE Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.4 Kuwait
      • 8.3.5.4.1 KuwaitEndometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.4 Reso of MEA
      • 8.3.5.4.1 Rest of MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 9 Endometriosis Treatment Market: Competitive Analysis

  • 9.1 Strategic Initiatives and Impact Analysis, by Key Market Participants
    • 9.1.1 Synergy Analysis: Major Deals and Strategic Alliances
      • 9.1.1.1 New Product Launches
      • 9.1.1.2 Mergers and Acquisitions
      • 9.1.1.3 Licensing Agreements
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
    • 9.2.3 Emerging Players
    • 9.2.4 Heat Map Analysis
  • 9.3 Company Market Position Analysis
  • 9.4 Vendor Landscape
    • 9.4.1 List of Key Distributors and Channel Partners
    • 9.4.2 List of Potential End-Users
    • 9.4.3 Key Company Market Share Analysis, 2021
    • 9.4.4 Consumer Behavior Analysis
    • 9.4.5 Competitive Dashboard Analysis
  • 9.5 Private Companies
    • 9.5.1 List of Key Emerging Companies
    • 9.5.2 Regional Network Map
  • 9.6 Company Profiles
    • 9.6.1 Bayer AG
      • 9.6.1.1 Company Overview
      • 9.6.1.2 Financial Performance
      • 9.6.1.3 Product Benchmarking
      • 9.6.1.4 Strategic Initiatives
    • 9.6.2 Pfizer, Inc
      • 9.6.2.1 Company Overview
      • 9.6.2.2 Financial Performance
      • 9.6.2.3 Product Benchmarking
      • 9.6.2.4 Strategic Initiatives
    • 9.6.3 AbbVie, Inc
      • 9.6.3.1 Company Overview
      • 9.6.3.2 Financial Performance
      • 9.6.3.3 Product Benchmarking
      • 9.6.3.4 Strategic Initiatives
    • 9.6.4 AstraZeneca
      • 9.6.4.1 Company Overview
      • 9.6.4.2 Financial Performance
      • 9.6.4.3 Product Benchmarking
      • 9.6.4.4 Strategic Initiatives
    • 9.6.5 ObsEva SA
      • 9.6.5.1 Company Overview
      • 9.6.5.2 Financial Performance
      • 9.6.5.3 Product Benchmarking
      • 9.6.5.4 Strategic Initiatives
    • 9.6.6 Teva Pharmaceutical Industries
      • 9.6.6.1 Company Overview
      • 9.6.6.2 Financial Performance
      • 9.6.6.3 Product Benchmarking
      • 9.6.6.4 Strategic Initiatives
    • 9.6.7 Zydus Healthcare Limited
      • 9.6.7.1 Company Overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product Benchmarking
      • 9.6.7.4 Strategic Initiatives
    • 9.6.8 Eli Lilly and Company
      • 9.6.8.1 Company Overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product Benchmarking
      • 9.6.8.4 Strategic Initiatives
    • 9.6.9 Astellas Pharma Inc
      • 9.6.9.1 Company Overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product Benchmarking
      • 9.6.9.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Endometriosis Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 Global Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 7 Global Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 Global Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 Global Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 North America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 12 North America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 13 North America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 North America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 U.S. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 U.S. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 U.S. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Canada Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 20 Canada Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Canada Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Canada Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Europe Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 24 Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 25 Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 26 Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Germany Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 29 Germany Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 Germany Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 Germany Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 U.K. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 33 U.K. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 34 U.K. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 35 U.K. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 France Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 37 France Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 38 France Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 France Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Italy Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 41 Italy Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Italy Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Italy Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Spain Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 45 Spain Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 46 Spain Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Spain Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Denmark Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 49 Denmark Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Denmark Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 51 Denmark Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Sweden Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 53 Sweden Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 54 Sweden Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 55 Sweden Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 Norway Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 57 Norway Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 58 Norway Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 Norway Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 Rest of Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 61 Rest of Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Rest of Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Rest of Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Japan Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 70 Japan Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Japan Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 72 Japan Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 China Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 74 China Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 75 China Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 76 China Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 India Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 78 India Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 79 India Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 India Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 81 South Korea Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 82 South Korea Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 83 South Korea Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 South Korea Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 Australia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 86 Australia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 87 Australia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 Australia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 Thailand Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 90 Thailand Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 91 Thailand Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 92 Thailand Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Rest of Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 94 Rest of Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 95 Rest of Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 96 Rest of Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 97 Latin America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 98 Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 99 Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 100 Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 101 Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 102 Brazil Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 103 Brazil Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 104 Brazil Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 105 Brazil Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 106 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 107 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 108 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 109 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 110 Argentina Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 111 Argentina Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 112 Argentina Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 113 Argentina Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 114 Rest of Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 115 Rest of Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 116 Rest of Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 117 Rest of Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 118 Middle East & Africa Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 119 Middle East & Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 120 Middle East & Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 121 Middle East & Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 122 Middle East & Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 123 Saudi Arabia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 124 Saudi Arabia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 125 Saudi Arabia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 126 Saudi Arabia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 127 South Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 128 South Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 129 South Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 130 South Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 131 UAE Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 132 UAE Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 133 UAE Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 134 UAE Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 135 Kuwait Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 136 Kuwait Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 137 Kuwait Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 138 Kuwait Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 139 Rest of MEA Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 140 Rest of MEA Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 141 Rest of MEA Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 142 Rest of MEA Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Endometriosis Treatment Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Commodity Flow Approach
  • Fig. 10 Market Snapshot (2022) (USD Million)
  • Fig. 11 Segment Snapshot (2022) (USD Million)
  • Fig. 12 Competitive Snapshot
  • Fig. 13 Penetration & Growth Prospect Mapping
  • Fig. 14 Endometriosis Treatment Market Driver Impact
  • Fig. 15 Endometriosis Treatment Market Restraint Impact
  • Fig. 16 PESTEL Analysis
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 Endometriosis Treatment, Treatment Type Outlook: Key Takeaways
  • Fig. 19 Endometriosis Treatment Market: Treatment Type Movement Analysis (USD Million)
  • Fig. 20 Pain Medication Market 2018 - 2030 (USD Million)
  • Fig. 21 Hormone Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 22 Endometriosis Treatment Market: Drug Class Movement Analysis (USD Million)
  • Fig. 23 NSAIDs Market, 2018 - 2030 (USD Million)
  • Fig. 24 Oral Contraceptive, Market, 2018 - 2030 (USD Million)
  • Fig. 25 Progestin Market, 2018 - 2030 (USD Million)
  • Fig. 26 Gonadotropin Releasing Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 27 Danazol Market, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Endometriosis Treatment, Route of Administartion Outlook: Key Takeaways
  • Fig. 30 Endometriosis Treatment Market: Route of Administartion Movement Analysis (USD Million)
  • Fig. 31 Oral Market, 2018 - 2030 (USD Million)
  • Fig. 32 Injectable Market, 2018 - 2030 (USD Million)
  • Fig. 33 Others Market, 2018 - 2030 (USD Million)
  • Fig. 34 Endometriosis Treatment Market Distribution Channel Outlook: Key Takeaways
  • Fig. 35 Hospital pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 36 Retail pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Snapshot, 2021 & 2030
  • Fig. 39 Regional Market Place: Key takeaways
  • Fig. 40 North America
  • Fig. 41 North America Endometriosis Treatment Market, 2018 - 2030 (USD million)
  • Fig. 42 U.S.
  • Fig. 43 U.S. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada
  • Fig. 45 Canada Endometriosis Treatment Market, 2018 - 2030 (USD million)
  • Fig. 46 Europe
  • Fig. 47 Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 48 U.K.
  • Fig. 49 U.K. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany
  • Fig. 51 Germany Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 52 Spain
  • Fig. 53 Spain Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 54 France
  • Fig. 55 France Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy
  • Fig. 57 Italy Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark
  • Fig. 57 Denmark Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden
  • Fig. 57 Sweden Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway
  • Fig. 57 Norway Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Rest of Europe
  • Fig. 57 Rest of Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific
  • Fig. 59 Asia Pacific Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan
  • Fig. 61 Japan Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 62 China
  • Fig. 63 China Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 64 India
  • Fig. 65 India Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 66 Australia
  • Fig. 67 Australia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea
  • Fig. 69 South Korea Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand
  • Fig. 71 Thailand Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 72 Rest of APAC
  • Fig. 73 Rest of APAC Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America
  • Fig. 75 Latin America Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil
  • Fig. 77 Brazil Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 78 Mexico
  • Fig. 79 Mexico Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina
  • Fig. 81 Argentina Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 82 Rest of LATAM
  • Fig. 83 Rest of LATAM Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 84 Middle East & Africa
  • Fig. 85 MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa
  • Fig. 87 South Africa Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia
  • Fig. 89 Saudi Arabia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 90 UAE
  • Fig. 91 UAE Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait
  • Fig. 93 Kuwait Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 94 Rest of MEA
  • Fig. 95 Rest of MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 96 Heat Map Analysis
  • Fig. 97 Company Market Position Analysis, 2021
  • Fig. 98 Company Market Position Analysis, 2021
  • Fig. 99 Company Market Share Analysis (2021)
  • Fig. 100 Consumer Behavior Analysis
  • Fig. 101 Market Differentiators